DDInter1074 DDInter1082
Liothyronine is a thyroidal hormone T3 which is normally produced by the thyroid gland in a ratio 4:1 when compared with T4: T3. Liothyronine is the active form of thyroxine which is composed in a basic chemical structure by a tyrosine with bound iodine. The exogenous liothyronine product was developed by King Pharmaceuticals and FDA approved in 1956.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Liothyronine {u} (Compound) resembles {v} (Compound) L-Tyrosine
Liothyronine {u} (Compound) treats {v} (Disease) hypothyroidism
Liothyronine {u} (Compound) binds {v} (Gene) SLCO4A1
Liothyronine {u} (Compound) upregulates {v} (Gene) TIPARP
Liothyronine {u} (Compound) is included by {v} (Pharmacologic Class) Triiodothyronine
Liothyronine {u} (Compound) causes {v} (Side Effect) Tachycardia
Liothyronine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Simvastatin
Liothyronine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Lovastatin
Liothyronine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Amiodarone
Liothyronine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Calcium acetate
Liothyronine (Compound) resembles L-Tyrosine (Compound)
Liothyronine (Compound) treats hypothyroidism (Disease)
Liothyronine (Compound) binds SLCO4A1 (Gene)
Liothyronine (Compound) upregulates TIPARP (Gene)
Liothyronine (Compound) is included by Triiodothyronine (Pharmacologic Class)
Liothyronine (Compound) causes Tachycardia (Side Effect)
Liothyronine may cause a minor interaction that can limit clinical effects when taken with Simvastatin
Liothyronine may cause a minor interaction that can limit clinical effects when taken with Lovastatin
Liothyronine may cause a moderate interaction that could exacerbate diseases when taken with Amiodarone
Liothyronine may cause a moderate interaction that could exacerbate diseases when taken with Calcium acetate